FDA Inspection 1249248 — InstaPill Private Limited

InstaPill Private Limited — FEI 3014463103

The FDA completed an inspection of InstaPill Private Limited on Sep 13, 2024 in Kanakapura Taluk, Ramanagara. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 13, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kanakapura Taluk, Ramanagara (India)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111121 CFR 211.25(a)Training , Education , Experience overall
191721 CFR 211.166(a)(1)Sample size - test intervals
202721 CFR 211.192Investigations of discrepancies, failures
358521 CFR 211.110(a)Control procedures to monitor and validate performance